BEIJING, March 18, 2011 /PRNewswire/ -- Kenneth C. Frazier, CEO of Merck (known as MSD outside the United States and Canada), will give a keynote speech at the 2nd Annual China Healthcare Investment Conference to be held from March 22-24, 2011 in Beijing. Mr. Frazier’s attendance is further testament to the significance of China as a key growth platform for leading global pharmaceutical companies like Merck.
Alongside Mr. Frazier, over 40 other well recognized senior healthcare executives including global and local CEOs, leading public and private investors and healthcare government officials will be speaking at this premier annual event. Together, they will be speaking to a high quality healthcare community audience of more than 300 attendees.
The annual China Healthcare Investment Conference focuses on introducing to the audience those Chinese healthcare companies that are most likely to succeed in the near future. It will bring together an elite group of both public and private healthcare companies that possess the highest growth potential. Last year’s inaugural event was a great success and boasted over 280 participants. Prominent China healthcare investors including key members from Fidelity Growth Partners Asia, KPCB, Piper Jaffray, Vivo Ventures and Burrill & Company are again leading the efforts to organize this prestigious annual event.
For details of the event go to: http://chinahic.com/
SOURCE Burrill & Company
